Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07450976
What this trial is testing

SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 151
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Testing effectiveness (Phase 2)Looking for participantsNCT06474468
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer

Who this might be right for
Advanced or Metastatic Esophageal Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 148
Not applicableWithdrawnNCT03946033
What this trial is testing

Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer

Who this might be right for
Colonic Neoplasms
UNICANCER
Early research (Phase 1)UnknownNCT02211443
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 21
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableLooking for participantsNCT06060990
What this trial is testing

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Who this might be right for
Trace Element Deficiency
Institute of Oncology Ljubljana 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04611997
What this trial is testing

IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Gastric CancerLymph Node Metastases
Fujian Medical University 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT04041310
What this trial is testing

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Who this might be right for
Solid Tumor, Adult
Nouscom SRL 115
Testing effectiveness (Phase 2)Ended earlyNCT01669720
What this trial is testing

Adjuvant Aflibercept for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Brown University 10
Not applicableActive Not RecruitingNCT05863052
What this trial is testing

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Who this might be right for
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more
University of Oklahoma 72
Testing effectiveness (Phase 2)Study completedNCT01139138
What this trial is testing

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
The Queen Elizabeth Hospital 49
Testing effectiveness (Phase 2)Looking for participantsNCT07685938
What this trial is testing

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Who this might be right for
Chest Wall TumorBreast CancerLung Cancer+6 more
UNC Lineberger Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)WithdrawnNCT00954876
What this trial is testing

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Genomics Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)WithdrawnNCT06603818
What this trial is testing

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal CancerColorectal Cancer
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT04745390
What this trial is testing

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Metastases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 110
Not applicableUnknownNCT06539806
What this trial is testing

Clinical Study Evaluating the Effect of Losartan

Who this might be right for
Pancreatic Cancer
Tanta University 90
Not applicableUnknownNCT06873178
What this trial is testing

The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerLiver MetastasesSurgery+1 more
China-Japan Friendship Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07011576
What this trial is testing

Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Who this might be right for
Colon CancerRectal CancerColorectal Cancer+1 more
SCRI Development Innovations, LLC 60
Next Page